http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201190127-A1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2853
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-284
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-60
filingDate 2010-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2012-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-201190127-A1
titleOfInvention PHARMACEUTICAL COMPOSITIONS OF NITAZOXANIDE WITH CONTROLLED DELIVERY
abstract Proposed solid dosage formulations of nitazoxanide or nitazoxanide analogue, which contain a controlled release part and an immediate release part. The pharmaceutical composition is typically in the form of a two-layer solid dosage form for oral administration, comprising: (a) a first layer containing the first amount of nigasoxanide or its analogue in a controlled release formulation: nitazoxanide or its analogue in the composition with immediate release. Also proposed a method of using the compositions for the treatment of hepatitis C.
priorityDate 2009-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41684
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414359002

Total number of triples: 28.